Myriad Genetics
MYGN
#6699
Rank
A$0.99 B
Marketcap
A$10.67
Share price
-3.27%
Change (1 day)
-57.92%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : A$0.21 Billion

According to Myriad Genetics's latest financial reports the company has A$0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.16 B-20.4%
2023-12-31A$0.20 B22.49%
2022-12-31A$0.16 B-63.87%
2021-12-31A$0.46 B
2020-06-30A$0.31 B61.89%
2019-06-30A$0.19 B-20.1%
2018-06-30A$0.24 B24.29%
2017-06-30A$0.19 B-8.05%
2016-06-30A$0.21 B13.42%
2015-06-30A$0.18 B-4.8%
2014-06-30A$0.19 B-51.53%
2013-06-30A$0.40 B22.67%
2012-06-30A$0.33 B2.85%
2011-06-30A$0.32 B-32.1%
2010-06-30A$0.47 B21.55%
2009-06-30A$0.39 B13.95%
2008-06-30A$0.34 B35.93%
2007-06-30A$0.25 B-17.87%
2006-06-30A$0.30 B106.37%
2005-06-30A$0.14 B-10.68%
2004-06-30A$0.16 B53.29%
2003-06-30A$0.10 B-16.29%
2002-06-30A$0.13 B-47.63%
2001-06-30A$0.24 B85.59%
2000-06-30A$0.13 B794.51%
1999-06-30A$14.97 M-36.33%
1998-06-30A$23.51 M13.1%
1997-06-30A$20.79 M24.01%
1996-06-30A$16.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
A$2.13 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
A$1.51 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A$9.98 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.22 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.64 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA